New definition of remission in childhood acute lymphoblastic leukemia

Leukemia

Volumn 14, Issue 5, 2000, Pages 783-785

  Pui, C H ^a,b   Campana, D ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Complete remission; Flow cytometry; Minimal residual leukemia; Polymerase chain reaction

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; CHILDHOOD LEUKEMIA; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMAN; IMMUNOPHENOTYPING; LEUKEMIA CELL; LEUKEMIA REMISSION; MINIMAL RESIDUAL DISEASE; PLASMA CLEARANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR GENE; REVIEW; RISK ASSESSMENT;

EID: 0034054159     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401780     Document Type: Review

References (16)

1. Gaynon PS, Desai AA, Bostrom BC, Hutchinson RJ, Lange BJ, Nachman JB, Reaman GH, Sather HN, Steinherz PG, Trigg ME, Tubergen DG, Uckun FM. Early response to therapy and outcome in childhood acute lymphoblastic leukemia. A review. Cancer 1997; 80: 1717-1726.
2. Lilleyman JS. Clincial importance of speed of response to therapy in childhood lymphoblastic leukaemia. Leuk Lymphoma 1998; 31: 501-506.
3. Silverman LB, Gelber RD, Young ML, Dalton VK, Barr RD, Sallan SE. Induction failure in acute lymphoblastic leukemia of childhood. Cancer 1999; 85: 1395-1404.
4. Campana D, Pui C-H. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood 1995; 85: 1416-1434.
5. Foroni L, Harrison CJ, Hoffbrand AV, Potter MN. Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis. Br J Haematol 1999; 105: 7-24.
6. Campana D, Coustan-Smith E. Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry 1999; 38: 139-152.
7. Coustan-Smith E, Behm FG, Sanchez J, Boyett JM, Hancock ML, Raimondi SC, Rubnitz JE, Rivera GK, Sandlund JT, Pui C-H, Campana D. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet 1998; 351: 550-554.
8. van Dongen JJM, Seriu T, Panzer-Grümayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van Wering ER, Ludwig W-D, Basso G, de Bruijn MAC, Gazzaniga G, Hettinger K, van der Does-van den Berg A, Hop WCJ, Riehm H, Bartram CR. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998; 352: 1731-1738.
9. Cavé H, van der Werff ten Bosch J, Suciu S, Guidal C, Waterkeyn C, Otten J, Bakkus M, Thielemans K, Grandchamp B, Vilmer E. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. New Engl J Med 1998; 339: 591-598.
10. Pui C-H, Evans WE. Acute lymphoblastic leukemia. New Engl J Med 1998; 339: 605-615.
11. Neale GAM, Coustan-Smith E, Pan Q, Chen X, Gruhn B, Stow P, Behm FG, Pui C-H, Campana D. Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia 1999; 13: 1221-1226.
12. Roberts WM, Estrov Z, Ouspenskaia MV, Johnston DA, McClain KL, Zipf TF. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. New Engl J Med 1997; 336: 317-323.
13. Pongers-Willemse MJ, Verhagen OJHM, Tibbe GJM, Wijkhuijs AJ, de Haas V, Roovers E, van der Schoot CE, van Dongen JJ. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia 1998; 12: 2005-2014.
14. Coustan-Smith E, Behm FG, Sancho J, Boyett JM, Hancock ML, Rivera GK, Rubnitz JE, Sandlund JT, Pui C-H, Campana D. Sequential monitoring of minimal residual disease in childhood acute lymphoblastic leukemia. Blood 1999; 94 (Suppl. 1): 626a.
15. Nachman JB, Sather HN, Sensel MG, Trigg ME, Cherlow JM, Lukens JN, Wolff L, Uckun FM, Gaynon PS. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. New Engl J Med 1998; 338: 1663-1671.
16. Chen J-S, Coustan-Smith E, Suzuki T, Neale GA, Pui C-H, Campana D. Identification of novel leukemia markers by comparative analysis of gene expression with DNA microarrays. Blood 1999; 94 (Suppl. 1): 657a.